Research advance and clinical implication of circZNF609 in human diseases

References

• Chen L-L, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388.
   PubMed Web of Science ®Google Scholar
• Wu H, Yang L, Chen L-L. The diversity of long noncoding RNAs and their generation. Trends Genet. 2017;33(8):540–552.
   PubMed Web of Science ®Google Scholar
• Zhai X, Zhang Y, Xin S, et al. Insights into the involvement of circular RNAs in autoimmune diseases. Front Immunol. 2021;12:622316.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye T, Liu H, et al. Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer. Mol Cancer. 2021;20(1):4.
   PubMed Web of Science ®Google Scholar
• Cocquerelle C, Mascrez B, Hétuin D, et al. Mis-splicing yields circular RNA molecules. Faseb J. 1993;7(1):155–160.
   PubMed Web of Science ®Google Scholar
• Nigro JM, Cho KR, Fearon ER, et al. Scrambled exons. Cell. 1991;64(3):607–613.
   PubMed Web of Science ®Google Scholar
• Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256–264.
   PubMed Web of Science ®Google Scholar
• Liu X, Hu Z, Zhou J, et al. Interior circular RNA. RNA Biol. 2020;17(1):87–97.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Trelles F, Tarrío R, Ayala F. Origins and evolution of spliceosomal introns. Annu Rev Genet. 2006;40:47–76.
   PubMed Web of Science ®Google Scholar
• Zhao X, Cai Y, Xu J. Circular RNAs: biogenesis, mechanism, and function in human cancers. IJMS. 2019;20(16):3926.
   Google Scholar
• Zhou W-Y, Cai Z-R, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.
   PubMed Web of Science ®Google Scholar
• Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 2021;12(12):911–946.
   PubMed Web of Science ®Google Scholar
• Shi X, Wang B, Feng X, et al. circRNAs and exosomes: a mysterious frontier for human cancer. Mol Ther Nucleic Acids. 2020;19:384–392.
   PubMedGoogle Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA (New York, N.Y.). 2013;19(2):141–157.
   PubMed Web of Science ®Google Scholar
• Huang C, Liang D, Tatomer DC, et al. A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs. Genes Dev. 2018;32(9-10):639–644.
   PubMed Web of Science ®Google Scholar
• Chen L-L. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–490.
   PubMed Web of Science ®Google Scholar
• Li J-q, Yang J, Zhou P[, et al. The biological functions and regulations of competing endogenous RNA. ]Yi Chuan. 2015;37(8):756–764.
   PubMedGoogle Scholar
• Huang A, Zheng H, Wu Z, et al. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503–3517.
   PubMed Web of Science ®Google Scholar
• Chen C, Yang Y, Wang Z. Study of circular RNA translation using reporter systems in living cells. Methods (San Diego, Calif.). 2021;196:113–120.
   PubMed Web of Science ®Google Scholar
• van Zonneveld AJ, Kölling M, Bijkerk R, et al. Circular RNAs in kidney disease and cancer. Nat Rev Nephrol. 2021;17(12):814–826.
   PubMed Web of Science ®Google Scholar
• Abe N, Matsumoto K, Nishihara M, et al. Rolling circle translation of circular RNA in living human cells. Sci Rep. 2015;5:16435.
   PubMed Web of Science ®Google Scholar
• Pamudurti NR, Bartok O, Jens M, et al. Translation of CircRNAs. Mol Cell. 2017;66(1):9–21.e7. e27.
   PubMed Web of Science ®Google Scholar
• Begum S, Yiu A, Stebbing J, et al. Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas. Oncogene. 2018;37(30):4055–4057.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang J, Zhang J, et al. CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Mol Cancer. 2021;20(1):101.
   PubMed Web of Science ®Google Scholar
• Legnini I, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66(1):22–37.e9. e29.
   PubMed Web of Science ®Google Scholar
• Xiao M-S, Wilusz JE. An improved method for circular RNA purification using RNase R that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends. Nucleic Acids Res. 2019;47(16):8755–8769.
   PubMed Web of Science ®Google Scholar
• Knupp D, Cooper DA, Saito Y, et al. NOVA2 regulates neural circRNA biogenesis. Nucleic Acids Res. 2021;49(12):6849–6862.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao F. Reconstruction of circular RNAs using illumina and nanopore RNA-seq datasets. Methods. 2021;196:17–22.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hou L, Zuo Z, et al. Comprehensive profiling of circular RNAs with nanopore sequencing and CIRI-long. Nat Biotechnol. 2021;39(7):836–845.
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94.
   PubMed Web of Science ®Google Scholar
• Bai Y, Zhang Y, Han B, et al. Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity. J Neurosci. 2018;38(1):32–50.
   PubMed Web of Science ®Google Scholar
• Wu P, Mo Y, Peng M, et al. Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 2020;19(1):22.
   PubMed Web of Science ®Google Scholar
• Geng Y, Jiang J, Wu C. Function and clinical significance of circRNAs in solid tumors. J Hematol Oncol. 2018;11(1):98.
   PubMed Web of Science ®Google Scholar
• Guarnerio J, Bezzi M, Jeong JC, et al. Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations. Cell. 2016;166(4):1055–1056.
   PubMedGoogle Scholar
• Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36.
   PubMed Web of Science ®Google Scholar
• Lux S, Bullinger L. Circular RNAs in cancer. Adv Exp Med Biol. 2018;1087:215–230.
   PubMed Web of Science ®Google Scholar
• Rybak-Wolf A, Stottmeister C, Glazar P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5):870–885.
   PubMed Web of Science ®Google Scholar
• Li L, Luo Y, Zhang Y, et al. CircZNF609 aggravates neuropathic pain via miR-22-3p/ENO1 axis in CCI rat models. Gene. 2020;763:145069.
   PubMed Web of Science ®Google Scholar
• Liu C, Yao MD, Li CP, et al. Silencing of circular RNA-ZNF609 ameliorates vascular endothelial dysfunction. Theranostics. 2017;7(11):2863–2877.
   PubMed Web of Science ®Google Scholar
• Wang S, Xue X, Wang R, et al. CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p. CMAR. 2018;ume 10:3881–3890.
   Google Scholar
• Liu Z, Pan HM, Xin L, et al. Circ-ZNF609 promotes carcinogenesis of gastric cancer cells by inhibiting miRNA-145-5p expression. Eur Rev Med Pharmacol Sci. 2019;23(21):9411–9417.
   PubMed Web of Science ®Google Scholar
• Wu W, Wei N, Shao G, et al. circZNF609 promotes the proliferation and migration of gastric cancer by sponging miR-483-3p and regulating CDK6. Onco Targets Ther. 2019;12:8197–8205.
   PubMed Web of Science ®Google Scholar
• Du S, Li H, Lu F, et al. Circular RNA ZNF609 promotes the malignant progression of glioma by regulating miR-1224-3p/PLK1 signaling. J Cancer. 2021;12(11):3354–3366.
   PubMed Web of Science ®Google Scholar
• Tong H, Zhao K, Wang J, et al. CircZNF609/miR-134-5p/BTG-2 axis regulates proliferation and migration of glioma cell. J Pharm Pharmacol. 2020;72(1):68–75.
   PubMed Web of Science ®Google Scholar
• Rossi F, Legnini I, Megiorni F, et al. Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma. Oncogene. 2019;38(20):3843–3854.
   PubMed Web of Science ®Google Scholar
• Wang J, Lin Y, Jiang DH, et al. CircRNA ZNF609 promotes angiogenesis in nasopharyngeal carcinoma by regulating miR-145/STMN1 axis. Kaohsiung J Med Sci. 2021;37(8):686–698.
   PubMed Web of Science ®Google Scholar
• He Y, Huang H, Jin L, et al. CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the hedgehog pathway through the regulation of miR-15a-5p/15b-5p and GLI2 expressions. Cell Death Dis. 2020;11(5):358.
   PubMed Web of Science ®Google Scholar
• Yang H, Li X, Meng Q, et al. CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer. Mol Cancer. 2020;19(1):13.
   PubMed Web of Science ®Google Scholar
• Li D, Li Z, Yang Y, et al. Circular RNAs as biomarkers and therapeutic targets in environmental chemical exposure-related diseases. Environ Res. 2020;180:108825.
   PubMed Web of Science ®Google Scholar
• Liu S, Yang N, Jiang X, et al. FUS-induced circular RNA ZNF609 promotes tumorigenesis and progression via sponging miR-142-3p in lung cancer. J Cell Physiol. 2021;236(1):79–92.
   PubMed Web of Science ®Google Scholar
• Wang F, Li X, Jia X, et al. CircRNA ZNF609 knockdown represses the development of Non-Small cell lung cancer via miR-623/FOXM1 axis. Cancer Manag Res. 2021;13:1029–1039.
   PubMed Web of Science ®Google Scholar
• Beltran M, Rossi F, Bozzoni I. CircZNF609 as a prototype to elucidate the biological function of circRNA-mRNA interactions. Mol Cell Oncol. 2022;9(1):2055939.
   PubMed Web of Science ®Google Scholar
• Rossi F, Beltran M, Damizia M, et al. Circular RNA ZNF609/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity. Mol Cell. 2022;82(1):75–89.e9. e9.
   PubMed Web of Science ®Google Scholar
• Thawani A, Kadzik RS, Petry S. XMAP215 is a microtubule nucleation factor that functions synergistically with the γ-tubulin ring complex. Nat Cell Biol. 2018;20(5):575–585.
   PubMed Web of Science ®Google Scholar
• Miller MP, Asbury CL, Biggins S. A TOG protein confers tension sensitivity to kinetochore-microtubule attachments. Cell. 2016;165(6):1428–1439.
   PubMed Web of Science ®Google Scholar
• Di Timoteo G, Dattilo D, Centrón-Broco A, et al. Modulation of circRNA metabolism by mA modification. Cell Rep. 2020;31(6):107641.
   PubMed Web of Science ®Google Scholar
• Ho-Xuan H, Glažar P, Latini C, et al. Comprehensive analysis of translation from overexpressed circular RNAs reveals pervasive translation from linear transcripts. Nucleic Acids Res. 2020;48(18):10368–10382.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol. 2014;16(7):896–913.
   PubMed Web of Science ®Google Scholar
• Ghouzlani A, Kandoussi S, Tall M, et al. Immune checkpoint inhibitors in human glioma microenvironment. Front Immunol. 2021;12:679425–679425.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li G, Han Y, et al. Circular RNA ZNF609 enhances proliferation and glycolysis during glioma progression by miR-378b/SLC2A1 axis. Aging (Albany NY). 2021;13(17):21122–21133.
   PubMedGoogle Scholar
• Zuo Y, Shen W, Wang C, et al. Circular RNA Circ-ZNF609 promotes lung adenocarcinoma proliferation by modulating miR-1224-3p/ETV1 signaling. Cancer Manag Res. 2020;12:2471–2479.
   PubMed Web of Science ®Google Scholar
• Yin X, Wang J, Shan C, et al. Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p. Bioengineered. 2022;13(3):6929–6941.
   PubMed Web of Science ®Google Scholar
• Li M, Li Y, Yu M. CircRNA ZNF609 knockdown suppresses cell growth via modulating miR-188/ELF2 axis in nasopharyngeal carcinoma. Onco Targets Ther. 2020;13:2399–2409.
   PubMed Web of Science ®Google Scholar
• Zhu L, Liu Y, Yang Y, et al. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p. Eur Rev Med Pharmacol Sci. 2019;23(7):2817–2826.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu F, Wang F, et al. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p. Mol Cell Biochem. 2021;476(1):175–186.
   PubMed Web of Science ®Google Scholar
• Yang CS, Lou Y, Ke QP[, et al. Mechanism of circZNF609 targeting miR-153 to regulate the proliferation and apoptosis of diffuse large B-cell lymphoma. ]. Zhonghua Zhong Liu Za Zhi. 2022;44(3):238–245.
   PubMedGoogle Scholar
• Liao X, Zhan W, Tian B, et al. Circular RNA ZNF609 promoted hepatocellular carcinoma progression by upregulating PAP2C expression via sponging miR-342-3p. Onco Targets Ther. 2020;13:7773–7783.
   PubMed Web of Science ®Google Scholar
• Wu L, Xia J, Yang J, et al. Circ-ZNF609 promotes migration of colorectal cancer by inhibiting Gli1 expression via microRNA-150. J BUON: Off J Balkan Union Oncol. 2018;23(5):1343–1349.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao Y, Kong P, et al. Expression of circZNF609 is down-regulated in colorectal cancer tissue and promotes apoptosis in colorectal cancer cells by upregulating p53. Med Sci Monit. 2019;25:5977–5985.
   PubMed Web of Science ®Google Scholar
• Guan C, Liu L, Zhao Y, et al. YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1. Aging (Albany NY). 2021;13(23):25195–25212. )
   PubMedGoogle Scholar
• Xiong Y, Zhang J, Song C. CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol. 2019;234(7):10646–10654.
   PubMed Web of Science ®Google Scholar
• Jin C, Zhao W, Zhang Z, et al. Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):3350–3358.
   PubMed Web of Science ®Google Scholar
• Du S, Zhang P, Ren W, et al. Circ-ZNF609 accelerates the radioresistance of prostate cancer cells by promoting the glycolytic metabolism through miR-501-3p/HK2 axis. Cancer Manag Res. 2020;12:7487–7499.
   PubMed Web of Science ®Google Scholar
• Gu Q, Hou W, Shi L, et al. Circular RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA-197-3p to promote the progression of cervical cancer progression. Bioengineered. 2021;12(1):927–936.
   PubMed Web of Science ®Google Scholar
• Shi P, Liu Y, Yang D, et al. CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer and by downregulating miR-514a-5p. Bioengineered. 2022;13(2):4372–4384.
   PubMed Web of Science ®Google Scholar
• Liu Q, Cui W, Yang C, et al. Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma. Aging (Albany NY). 2021;13(15):19822–19834.
   PubMedGoogle Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Campion NJ, Ally M, Jank BJ, et al. The molecular march of primary and recurrent nasopharyngeal carcinoma. Oncogene. 2021;40(10):1757–1774.
   PubMed Web of Science ®Google Scholar
• Guo L-L, Wang H-Y, Zheng L-S, et al. Metastasis of nasopharyngeal carcinoma: what we know and do not know. Vis Cancer Med. 2021;2:4.
   Google Scholar
• Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50(1):74–87.
   PubMed Web of Science ®Google Scholar
• Craig AJ, von Felden J, Garcia-Lezana T, et al. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17(3):139–152.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2(1):16018.
   PubMedGoogle Scholar
• Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.
   PubMed Web of Science ®Google Scholar
• Janney A, Powrie F, Mann EH. Host-microbiota maladaptation in colorectal cancer. Nature. 2020;585(7826):509–517.
   PubMed Web of Science ®Google Scholar
• Aran V, Victorino AP, Thuler LC, et al. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer. 2016;15(3):195–203.
   PubMed Web of Science ®Google Scholar
• Ho-Xuan H, Lehmann G, Glazar P, et al. Gene expression signatures of a preclinical mouse model during colorectal cancer progression under low-dose metronomic chemotherapy. Cancers (Basel). 2020;13(1):49.
   PubMed Web of Science ®Google Scholar
• Saha SK, Zhu AX, Fuchs CS, et al. Forty-Year trends in cholangiocarcinoma incidence in the U.S. Oncologist. 2016;21(5):594–599.
   PubMed Web of Science ®Google Scholar
• Shelar S, Shim E-H, Brinkley GJ, et al. Biochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancer. Clin Cancer Res. 2018;24(24):6433–6446.
   PubMed Web of Science ®Google Scholar
• Chen P, Pan X, Zhao L, et al. MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma. Exp Ther Med. 2018;15(2):1686–1693.
   PubMed Web of Science ®Google Scholar
• Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894–906.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Chen R-J, Hung C-M, Chen Y-L, et al. Monascuspiloin induces apoptosis and autophagic cell death in human prostate cancer cells via the Akt and AMPK signaling pathways. J Agric Food Chem. 2012;60(29):7185–7193.
   PubMed Web of Science ®Google Scholar
• Sheng X, Li W-B, Wang D-L, et al. Yap is closely correlated with castration-resistant prostate cancer, and downregulation of Yap reduces proliferation and induces apoptosis of PC-3 cells. Mol Med Rep. 2015;12(4):4867–4876.
   PubMed Web of Science ®Google Scholar
• Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441–464.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu Z, Ding J, et al. HZ08 suppresses RelB-activated MnSOD expression and enhances radiosensitivity of prostate cancer cells. J Exp Clin Cancer Res. 2018;37(1):174.
   PubMedGoogle Scholar
• Fotouhi Ghiam A, Taeb S, Huang X, et al. Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer. Oncotarget. 2017;8(3):4668–4689.
   PubMedGoogle Scholar
• Angahar LT. An overview of breast cancer epidemiology, risk factors, pathophysiology, and cancer risks reduction. MOJBM. 2017;1(4):92–96.
   Google Scholar
• Wen Y, Zhang S, Yang J, et al. Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration. Biomed Pharmacother. 2019;120:109546.
   PubMed Web of Science ®Google Scholar
• Goodman A. HPV testing as a screen for cervical cancer. BMJ. 2015;350:h2372.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–653.
   PubMed Web of Science ®Google Scholar
• Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16(1):17–29.
   PubMed Web of Science ®Google Scholar
• Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13(3):184–199.
   PubMed Web of Science ®Google Scholar
• Almacellas-Rabaiget O, Monaco P, Huertas-Martinez J, et al. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity. Cancer Lett. 2020;474:1–14.
   PubMed Web of Science ®Google Scholar
• Skapek SX, Ferrari A, Gupta AA, et al. Rhabdomyosarcoma. Nat Rev Dis Primers. 2019;5(1):1–1.
   PubMed Web of Science ®Google Scholar
• Sun X, Guo W, Shen JK, et al. Rhabdomyosarcoma: advances in molecular and cellular biology. Sarcoma. 2015;2015:232010.
   PubMedGoogle Scholar
• Egas-Bejar D, Huh WW. Rhabdomyosarcoma in adolescent and young adult patients: current perspectives. AHMT. 2014;5:115–125.
   Google Scholar
• Giugliano F, Crimini E, Tarantino P, et al. First line treatment of BRAF mutated advanced melanoma: does one size fit all? Cancer Treat Rev. 2021;99:102253.
   PubMed Web of Science ®Google Scholar
• Marzagalli M, Ebelt ND, Manuel ER. Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Semin Cancer Biol. 2019;59:236–250.
   PubMed Web of Science ®Google Scholar
• Paluncic J, Kovacevic Z, Jansson PJ, et al. Roads to melanoma: key pathways and emerging players in melanoma progression and oncogenic signaling. Biochim Biophys Acta. 2016;1863(4):770–784.
   PubMed Web of Science ®Google Scholar
• Olive PL, Banáth JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc. 2006;1(1):23–29.
   PubMed Web of Science ®Google Scholar
• Arshad A, Powell C, Tighe MP. Hirschsprung’s disease. BMJ. 2012;345:e5521.
   PubMedGoogle Scholar
• Peng L, Chen G, Zhu Z, et al. Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in hirschsprung’s disease. Oncotarget. 2017;8(1):808–818.
   PubMedGoogle Scholar
• Cui X, Fu J, Luan J, et al. CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p. Biochem Biophys Res Commun. 2020;531(3):341–349.
   PubMed Web of Science ®Google Scholar
• Ge R, Gao G. Anti-antioxidant impacts of circZNF609 silence in HaCaT cells through regulating miR-145. Artif Cells Nanomed Biotechnol. 2020;48(1):384–392.
   PubMed Web of Science ®Google Scholar
• Wu P, Zhang D, Geng Y, et al. Circular RNA-ZNF609 regulates corneal neovascularization by acting as a sponge of miR-184. Exp Eye Res. 2020;192:107937.
   PubMed Web of Science ®Google Scholar
• Liang B, Li M, Deng Q, et al. CircRNA ZNF609 in peripheral blood leukocytes acts as a protective factor and a potential biomarker for coronary artery disease. Ann Transl Med. 2020;8(12):741–741.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Liu C, Shan K, et al. Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge. Theranostics. 2018;8(12):3408–3415.
   PubMed Web of Science ®Google Scholar
• Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017;12(3):502–517.
   PubMed Web of Science ®Google Scholar
• Xu X, Wang G, Chen N, et al. Long-Term exposure to air pollution and increased risk of membranous nephropathy in China. JASN. 2016;27(12):3739–3746.
   Web of Science ®Google Scholar
• Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007;71(12):1205–1214.
   PubMed Web of Science ®Google Scholar
• Agrawal K, Chauhan N. Pressure ulcers: back to the basics. Indian J Plast Surg. 2012;45(2):244–254.
   PubMedGoogle Scholar
• Meek KM, Knupp C. Corneal structure and transparency. Prog Retin Eye Res. 2015;49:1–16.
   PubMed Web of Science ®Google Scholar
• Nicholas MP, Mysore N. Corneal neovascularization. Exp Eye Res. 2021;202:108363.
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021;101(1):259–301.
   PubMed Web of Science ®Google Scholar
• Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc. 2015;90(4):532–545.
   PubMed Web of Science ®Google Scholar
• van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–662.
   PubMed Web of Science ®Google Scholar
• Puro DG, Kohmoto R, Fujita Y, et al. Bioelectric impact of pathological angiogenesis on vascular function. Proc Natl Acad Sci U S A. 2016;113(35):9934–9939.
   PubMed Web of Science ®Google Scholar
• Qian Y, Li Y, Li R, et al. circ-ZNF609: a potent circRNA in human cancers. J Cell Mol Med. 2021;25(22):10349–10361.
   PubMed Web of Science ®Google Scholar
• Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017;18(6):331–344.
   PubMed Web of Science ®Google Scholar
• Tardif J-C, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497–2505.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, CANTOS Trial Group, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131.
   PubMed Web of Science ®Google Scholar
• Almasieh M, Wilson AM, Morquette B, et al. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res. 2012;31(2):152–181.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhou J, Starr C, et al. Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell. 2021;184(16):4299–4314.e12.
   PubMed Web of Science ®Google Scholar